Combining different cannabinoids, specifically delta-9-tetrahydrocannabinol (delta 9 thc) and cannabidiol (CBD), presents a nuanced approach to cannabis consumption. The intended outcome is to leverage the distinct properties of each compound to achieve a modified or enhanced experience. This involves understanding the potential synergistic or antagonistic interactions between these substances.
The practice of blending cannabinoids is rooted in the observation that individual cannabinoids exert unique effects on the body’s endocannabinoid system. The inclusion of CBD, for example, is often considered to mitigate some of the potential adverse effects associated with delta 9 thc, such as anxiety or paranoia. Furthermore, some users believe a carefully balanced combination can optimize therapeutic benefits by targeting multiple receptors within the endocannabinoid system simultaneously.